Avacta Group PLC on Monday celebrated rapid progress on its joint venture in South Korea, following a second equity payment.
The Wetherby, England-based life sciences company said that the payment. | June 5, 2023
Wetherby-based life sciences company Avacta Group has made “rapid progress” with a joint venture project in Southy Korea to develop next-generation cell therapies.
Life science company Avacta Group announced on Monday that a second milestone equity payment had been triggered, resulting in an increased shareholding for Avacta in AffyXell Therapeutics.
Acquisition consistent with Avacta Diagnostics M&A strategy and complements earlier acquisition of Launch Diagnostics Avacta Group plc , a life sciences company developing. | June 1, 2023